| JPMorgan Equity Premium Income Active ETF (Managed Fund) (Hedged) (JHPI) |
Financials |
$10 |
Distribution Notice
|
25 Feb 2026 1:39PM |
$52.790 |
$51.510 |
fallen by
2.42%
|
|
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$25 |
H1 FY26 Investor Presentation
|
25 Feb 2026 1:35PM |
$0.046 |
$0.037 |
fallen by
19.57%
|
|
VIT - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY2026 revenue $67.9 million, up 8.3% vs PCP.
- Medicinal cannabis and nicotine vaping products drive revenue growth.
- Normalized EBITDA $1.9M, down from $4.6M in PCP.
- Leadership transitions include a new CFO and interim executive director.
- Acquisition of Candor Medical adds 15,000 active patients.
- Canview platform shows a 10.2% increase in unit sales.
- Company focus on market position and margin improvements.
- 21% revenue growth in Doctors on Demand services.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Tungsten and Antimony Ltd (AT4) ORDINARY FULLY PAID |
Materials |
$113 |
AT4 Tungsten Strategy - Investor Webinar
|
25 Feb 2026 1:30PM |
$0.143 |
$0.084 |
fallen by
41.05%
|
|
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$25 |
H1 FY26 Results Release
|
25 Feb 2026 1:29PM |
$0.046 |
$0.037 |
fallen by
19.57%
|
|
VIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue of $67.9 million, up 8.3% from H1 FY2025.
- Normalised EBITDA decreased to $1.9 million from $4.6 million.
- Net profit after tax saw a loss of $1.0 million.
- Medicinal cannabis and Nicotine Vaping Products were key revenue drivers.
- Doctors on Demand telehealth service revenue grew by 21%.
- Leadership transition to focus on accelerated execution and cost reduction.
- Management restructure resulted in 10% operational expenditure reduction.
- Nicotine Vaping Product segment exceeded revenue expectations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$25 |
H1 FY26 Results Investor Webinar
|
25 Feb 2026 1:28PM |
$0.046 |
$0.037 |
fallen by
19.57%
|
|
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$25 |
H1 FY26 Appendix 4D and Half Year Report
|
25 Feb 2026 1:26PM |
$0.046 |
$0.037 |
fallen by
19.57%
|
|
VIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitura Health Limited reported a total comprehensive loss of AUD 915,728 for the half-year ended 31 December 2025.
- Revenue increased to AUD 67,871,021 from AUD 62,672,501 in the previous year.
- The company had a gross profit of AUD 15,432,128, which decreased from AUD 16,861,292 in the prior period.
- The loss before income tax was AUD 638,312, compared to a profit of AUD 2,528,508 in the previous year.
- Significant expenses included personnel expenses of AUD 10,016,590 and finance costs of AUD 657,637.
- Cash and cash equivalents decreased to AUD 6,100,366 at the end of the period from AUD 7,579,097 at the beginning.
- Total equity decreased to AUD 45,360,263 from AUD 47,600,775 as of 30 June 2025.
- The report included a Directors’ Declaration and an Auditor's Independence Declaration.
- A segment analysis showed that the sales and distribution segment generated significant revenue, but the clinics and services segment recorded a loss.
- Vitura Health Limited is headquartered in Melbourne, Australia, and operates primarily within the Australian market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ambertech Limited (AMO) ORDINARY FULLY PAID |
Information Technology |
$12 |
Results Webinar
|
25 Feb 2026 1:25PM |
$0.150 |
$0.125 |
fallen by
16.67%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$10 |
Half Year Report and Appendix 4D
|
25 Feb 2026 1:24PM |
$0.014 |
$0.013 |
fallen by
7.14%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss of $2,898,554 reported for the half-year ending 31 December 2025.
- Revenue decreased by 3.2% to $997,178.
- Significant progress in commercial execution and strategic partnerships.
- Deployment of PROTEQT™ mouthguards at the Winter Olympics.
- Entry into the North American market and retail distribution with Rebel Sport.
- No dividends paid, recommended, or declared during this period.
- Need for additional capital to meet commitments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gentrack Group Limited (GTK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$579 |
Annual Shareholder Meeting Results
|
25 Feb 2026 1:22PM |
$6.480 |
$5.150 |
fallen by
20.52%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$10 |
Change of Director's Interest Notice
|
25 Feb 2026 1:20PM |
$0.200 |
$0.140 |
fallen by
30%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$10 |
Change in substantial holding
|
25 Feb 2026 1:16PM |
$0.200 |
$0.140 |
fallen by
30%
|
|
| Retail Food Group Limited (RFG) ORDINARY FULLY PAID |
Consumer Discretionary |
$61 |
New NED Appointments & Extension of Chairman's Employment
|
25 Feb 2026 1:15PM |
$1.090 |
$0.960 |
fallen by
11.93%
|
|
| Carnegie Clean Energy Limited (CCE) ORDINARY FULLY PAID |
Utilities |
$24 |
Half Yearly Report and Accounts
|
25 Feb 2026 1:15PM |
$0.059 |
$0.060 |
risen by
1.69%
|
|
CCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax for the period was $1,705,035.
- Sales revenue for the half-year increased by 45.4% to $237,708.
- Carnegie's principal activities included the development of CETO technology and MoorPower.
- Product development supported by the ACHIEVE Programme and international collaborations.
- Shares issued to improve capital and cash position.
- Garden Island Microgrid contributed significantly to revenue.
- Engagement in several funded project contracts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Vintage Ltd (AVG) ORDINARY FULLY PAID |
Consumer Staple |
$25 |
Change of Director's Interest Notice - James Williamson
|
25 Feb 2026 1:13PM |
$0.086 |
$0.077 |
fallen by
10.47%
|
|
| Australian Finance Group Ltd (AFG) ORDINARY FULLY PAID |
Financials |
$499 |
Ceasing to be a substantial holder from CBA
|
25 Feb 2026 1:09PM |
$1.835 |
$1.835 |
fallen by
0%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$307,114 |
Ceasing to be a substantial holder for AFG
|
25 Feb 2026 1:09PM |
$179.765 |
$183.520 |
risen by
2.09%
|
|
| Acorn Capital Investment Fund Limited (ACQ) ORDINARY FULLY PAID |
Financials |
$85 |
Dividend/Distribution - ACQ
|
25 Feb 2026 1:07PM |
$0.980 |
$0.950 |
fallen by
3.06%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$3,213 |
Court approves Scheme Meeting & Scheme Booklet distribution
|
25 Feb 2026 1:07PM |
$4.675 |
$4.790 |
risen by
2.46%
|
|
IFL - Price-sensitive ASX Announcement
Full Release
Key Points
- Federal Court of Australia approved the Scheme Meeting and distribution of Scheme Booklet.
- Proposed acquisition by Daintree BidCo Pty Ltd via scheme of arrangement.
- Scheme Meeting scheduled for 13 April 2026.
- Scheme Booklet to be dispatched by 4 March 2026.
- Independent Expert’s Report concludes the Scheme is fair and reasonable.
- Insignia Financial Board recommends shareholders vote in favor of the Scheme.
- Scheme Consideration of $4.80 per share is within the assessed value range.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acorn Capital Investment Fund Limited (ACQ) ORDINARY FULLY PAID |
Financials |
$85 |
Half Year Accounts - Appendix 4D
|
25 Feb 2026 1:06PM |
$0.980 |
$0.950 |
fallen by
3.06%
|
|
ACQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $22.921 million, up 306% from the previous year.
- Profit before tax rose to $22.042 million, a 366% increase.
- Profit after tax attributable to members was $15.419 million, a 359% increase.
- Declared interim dividend of 3.50 cents per share, fully franked at 30%.
- Dividend reinvestment plan (DRP) will apply to this and future dividends.
- Net tangible asset backing per share post-tax was $1.2533.
- Financial report reviewed by Ernst & Young for compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$3 |
Appendix 4D & Half Year Report 31 December 2025
|
25 Feb 2026 1:04PM |
$0.010 |
$0.009 |
fallen by
10%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities decreased by 66% to $177,564.
- Net loss after tax decreased by 56% to $514,975.
- The Anti-Obesity Project's compound AOC showed significant activity in pre-clinical studies.
- Delays in Mechanism of Action studies due to international unavailability of a testing kit.
- Successful GaRP-IBS Phase II trial completion.
- Completed a capital raising of A$1.2 million.
- Focused on unmet medical needs in gastrointestinal health.
- Cash at the end of the half year was $1.085 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$156 |
Stealth 1H FY26 Briefing Presentation
|
25 Feb 2026 1:02PM |
$1.280 |
$1.040 |
fallen by
18.75%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Record sales of $82.2 million, an 11.8% increase.
- Acquisition of Hardware & Building Traders (HBT) strengthens market position.
- Increased EBITDA of $5.4 million and net profit after tax of $1.6 million.
- Cash balance increased by 212.5% to $32.5 million.
- Focus on leveraging national distribution platform and procurement scale.
- Strong balance sheet with low net debt for future investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPM Minerals Limited (BPM) ORDINARY FULLY PAID |
Materials |
$33 |
Notice of General Meeting/Proxy Form
|
25 Feb 2026 1:01PM |
$0.335 |
$0.255 |
fallen by
23.88%
|
|
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$156 |
Stealth delivers record half year result
|
25 Feb 2026 1:01PM |
$1.280 |
$1.040 |
fallen by
18.75%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Record half-year financial performance with $82.2 million in gross sales.
- Revenue increased to $72.0 million, with EBITDA rising by 18.8%.
- NPAT increased by 51.4%, reaching $1.6 million.
- Acquisition of Hardware & Building Traders (HBT) added 1,165 independent stores.
- Stealth aims for $500 million+ sales by FY28 with a capital-light model.
- Focus on procurement leverage, exclusive brands, and operational efficiency.
- Strengthened balance sheet with a $19.5 million capital raise.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$156 |
Half Yearly Report and Accounts
|
25 Feb 2026 1:00PM |
$1.280 |
$1.040 |
fallen by
18.75%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Stealth Group Holdings Ltd reported record half-year sales of $82.2 million, an increase of 11.8% from the previous year.
- The company achieved revenue of $72.0 million, up 0.7% from the prior period, and maintained its gross profit margin.
- The underlying EBITDA increased by 17.5% to $5.4 million.
- Net Profit After Tax (NPAT) rose by 1.56% to $1.6 million.
- Operating cash inflow was $1.6 million, with net assets amounting to $49.5 million as of 31 December 2025.
- Stealth Group Holdings completed a $19.5 million capital raising and acquired Hardware & Building Traders Pty Limited.
- The company increased its net assets by $19.3 million from 30 June 2025.
- Intangible assets grew significantly due to acquisitions, with goodwill from acquisitions reaching $42.96 million.
- The balance sheet and cash flows are reported to have strengthened, supporting future growth and transformation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$50 |
Imugene Receives $2.7M R&D Tax Refund
|
25 Feb 2026 12:52PM |
$0.250 |
$0.140 |
fallen by
44%
|
|
Call 1300 880 160
Start a chat
Schedule a call
